HEAR FROM PEOPLE WITH DIABETES ON TIME IN RANGE (TIR)
Hear real stories from actual patients highlighting the impact of TIR
Patient with type 1 diabetes has received a fee from Novo Nordisk Inc. for his participation.
LASSE’S EXPERIENCE WITH TIR
Type 1 diabetes, Denmark
Patient with type 2 diabetes has received a fee from Novo Nordisk Inc. for her participation.
MARY’S EXPERIENCE WITH TIR
”Time in Range definitely helped me to take better control in a sense that I was able to determine whether my treatment plan was working or if it wasn't. It's important to have the real-time data from the CGM.”